Home » Topics » BioWorld Science

BioWorld Science
RSS

Bavarian Nordic highlights Imvamune progress

June 18, 2004

Clinical response found with eculizumab in rheumatoid arthritis

June 17, 2004

Preliminary data on the efficacy of epratuzumab in SLE

June 17, 2004

New monoamine reuptake inhibitors developed at NeuroSearch

June 17, 2004

Novel chemokine CCR1 antagonists and their use covered by Pfizer patent

June 17, 2004

T-614 reported safe and effective in patients with active rheumatoid arthritis

June 17, 2004

Dual alpha7 nAChR agonists/5-HT3 antagonists for psychosis, cognition disorders, etc.

June 17, 2004

New antilipolytic agents targeting hRUP38 receptors

June 17, 2004

Boehringer Ingelheim scientists describe new ICAM-1/LFA-1 interaction inhibitors

June 17, 2004

Two series of gamma-secretase inhibitors identified at Merck

June 17, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...